In the last 90 days, Cannabis Bioscience International Holdings Inc. saw one insider transaction: a proposed sale of 50 million shares valued at $12,500 by CEO Dante Picazo. This occurred against a backdrop of a 25% stock price decline over the same period. No buy transactions were reported.